Advanced Biomed reported net income of -$0.52M for the quarter ended Mar 2026. This income statement covers 10 quarters of results from Dec 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | 1.08M | 1.08M | 1.08M | 1.08M | 1.38M |
| Operating items | ||||||||||
| Research & DevelopmentR&D | 0.19M | 0.31M | 0.21M | 0.18M | 0.21M | 0.22M | 0.31M | 0.24M | 0.19M | 0.24M |
| Selling, General & AdministrativeSG&A | 0.46M | 0.43M | 0.50M | 0.34M | 0.07M | 0.35M | 1.64M | 0.29M | 0.21M | 0.28M |
| Operating ExpensesOpex | 0.65M | 0.75M | 0.70M | 0.52M | 0.28M | 0.57M | 1.95M | 0.52M | 0.40M | 0.52M |
| EBIT | -0.15M | -1.06M | -0.81M | -0.27M | -0.58M | -1.20M | -1.50M | -0.39M | 7.00M | -0.49M |
| Non-operating items | ||||||||||
| Non Operating Investment Income | 7.35M | |||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 104.00 | 0.03M | 10.00 | 0.02M | -90.00 | 0.01M | 448.00 | 0.01M | -112.00 |
| Other Non Operating IncomeOther Non Op Inc. | 0.49M | -0.31M | 2.18M | 1.97M | -0.31M | -0.63M | 3.59M | 2.93M | 0.04M | 0.03M |
| Non Operating IncomeNon Op. Inc. | 0.51M | -0.31M | -0.10M | 0.25M | -0.30M | -0.63M | 0.45M | 0.14M | 7.40M | 0.03M |
| Net income details | ||||||||||
| EBT | -0.15M | -1.06M | -0.81M | -0.27M | -0.58M | -1.20M | -1.50M | -0.39M | 7.00M | -0.49M |
| Profit After TaxPAT | -0.61M | -1.06M | -0.81M | -0.57M | -0.91M | -1.38M | -0.70M | -0.47M | 7.00M | -0.52M |
| Income from Continuing OperationsIncome (Continuing) | -0.15M | -1.06M | -0.81M | -0.27M | -0.58M | -1.20M | -1.50M | -0.39M | 7.00M | -0.49M |
| Income from Discontinued OperationsIncome (Discontinued) | -0.33M | -0.19M | -0.14M | |||||||
| Consolidated Net IncomeConsol Net Inc. | -0.15M | -1.06M | -0.81M | -0.27M | -0.91M | -1.38M | -1.50M | -0.39M | 6.86M | -0.49M |
| Income towards Parent CompanyParent Net Inc | -0.15M | -1.06M | -0.81M | -0.27M | -0.91M | -1.38M | -1.50M | -0.39M | 6.86M | -0.49M |
| Net Income towards Common StockholdersNet Income | -0.15M | -1.06M | -0.81M | -0.27M | -0.91M | -1.38M | -1.50M | -0.39M | 6.86M | -0.49M |
| Additional items | ||||||||||
| EPS (Basic) | -0.15 | -1.06 | -0.81 | -0.27 | -0.91 | -1.35 | -1.46 | -0.36 | 6.34 | -0.38 |
| EPS (Diluted) | -0.15 | -1.06 | -0.81 | -0.27 | -0.91 | -1.35 | -1.46 | -0.36 | 6.34 | -0.38 |
| Shares Outstanding | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | 1.02M | 1.03M | 1.08M | 1.08M | 1.28M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | 1.02M | 1.03M | 1.08M | 1.08M | 1.28M |
| EBITDA | -0.15M | -1.06M | -0.81M | -0.27M | -0.58M | -1.20M | -1.50M | -0.39M | 7.00M | -0.49M |